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In inherited long QT syndrome (LQTS), female sex is
associated with a longer QT interval duration and a higher
risk for potentially lethal polymorphic ventricular tachy-
cardia (pVT) and sudden cardiac death than in males.1,2 The
arrhythmogenic risk is particularly pronounced during the
postpartum period—especially in patients with LQTS type
2—but relatively low during pregnancy,3 indicating a
potential role for sex hormones in modulating cardiac
repolarization and arrhythmogenesis in LQTS. In patients
with the acquired, drug-induced LQTS variant, hormone-
induced changes in QT interval duration during different
phases of the menstrual cycle have been described, with a
less pronounced drug-induced QT interval prolongation
and hence shorter QT intervals during the luteal phase,
when progesterone levels are high, than during the fol-
licular phase with its high estradiol levels.4 Moreover,
postmenopausal hormone replacement therapy in healthy
women was found to prolong QT duration in women treated
with estradiol alone but did not alter QT duration when
combinations of estradiol and progesterone were used.5
However, despite the use of the heart rate–corrected QTc
duration for risk stratiﬁcation in LQTS patients,2 to date,
the effects of sex hormones and their withdrawal during
different phases of menstrual cycle, pregnancy, and post-
partum on QT interval duration have not been investigated
systematically in patients with inherited LQTS—except for
1 recent report on menstrual cycle–related changes in QT
duration in 1 LQTS family.6KEYWORDS Long QT syndrome; Sex hormones; Pregnancy; Postpartum;
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We here present the case and a series of electrocardiogram
(ECG) recordings of a 37-year-old female LQTS patient,
who was regularly followed in our arrhythmia outpatient
clinic since 2002.
Initial presentation
In 1999, at the age of 21 years, the patient was initially
diagnosed with epilepsy owing to several syncopal episodes
and was consequently started on antiepileptic medication
topiramate (100 mg twice daily) and carbamazepine (800 mg
twice daily). Despite this treatment, she experienced 3 more
syncopal episodes in 2000, all of which were triggered by
auditory stimuli. The ﬁrst of these syncopal episodes
occurred in February 2000, when she was startled (by a
knock on the door) while watching a horror movie. She was
taken to a local emergency department and an ECG was
notable for sinus rhythm and a prolonged heart rate–
corrected QT interval (QTc) of 500 ms. The patient was
consecutively diagnosed with LQTS. The second episode
occurred in April 2000, when she was sleeping in a car and a
noise woke her up. The third episode took place after she had
already been placed on beta-blocker therapy (atenolol 25 mg
once a day), when a jackhammer went off while she was
at work.
Subsequently, given the failure of a standard beta-blocker
therapy, a single-chamber implantable cardioverter-deﬁbri-
llator (ICD; St. Jude Medical, Proﬁle; St. Paul, MN) was
implanted in August 2000 and the beta-blocker therapy was
changed to metoprolol succinate 50 mg daily. At the time of
the diagnosis and during the following years (2000–2002),
all ECG recordings showed a QTc duration ranging from 500
to 575 ms. Following the ICD implantation, our patient
experienced 1 inappropriate shock due to exercise-induced
sinus tachycardia (188 beats/min), but has not experienced
additional pVT episodes. In June 2003, her ICD was
replaced (Medtronic, Marquis; Minneapolis, MN).pen access article under the CC BY-NC-ND license
http://dx.doi.org/10.1016/j.hrcr.2015.12.012
KEY TEACHING POINTS
 In patients with inherited long QT syndrome, heart
rate–corrected QT interval (QTc) duration (and
consecutive arrhythmogenic risk) may vary
pronouncedly with changing sex hormone levels.
 For adequate risk assessment, QTc duration should
be assessed repetitively in female LQTS patients—
ideally at different phases of the menstrual cycle,
during pregnancy, and postpartum.
 One single measurement of a normal QTc does not
exclude the diagnosis "long QT syndrome."
Heart Rhythm Case Reports, Vol 2, No 3, May 2016224Although her medical history is suggestive of LQTS type
2, so far none of the known deleterious HERG/KCNH2
mutations were found, nor has any other known LQTS
mutation been detected in any of the sequenced genes
(FAMILON Comprehensive Test for the genes KCNQ1
[LQT1], KCNH2 [LQT2], SCN5A [LQT3], KCNE1
[LQT5], KCNE2 [LQT6)], KCNJ2 [LQT7], CACNA1C
[LQT8], CAV3 [LQT9], SCN4B [LQT10], AKAP9
[LQT11], SNTA1 [LQT12], and KCNJ5 [LQT13], reported
sensitivity 75%, done in June 2012). However, a poly-
morphism in KCNE1 (Asp 85 Asn), the beta-subunit to
KCNQ1/KvLQT1, was detected. This polymorphism may
play a role in drug-induced LQTS and has been observed
more frequently in LQTS patients, where it contributes to the
clinical phenotype (QT duration, arrhythmogenic events).7
Her father and mother have normal QTc durations, and there
have been no conﬁrmed cases of sudden death in the family,
although her maternal uncle died in his 20s, reportedly of a
seizure, and a maternal cousin drowned at 16 years of age
with no apparent cause. No ECG recordings had been
acquired in these relatives.Presentation in our clinic
We began treating the patient in 2002 in our outpatient
arrhythmia clinic at Rhode Island Hospital. In the ﬁrst 3
years, we regularly observed a prolonged QTc duration of
greater than 500 ms in all of her ECG recordings. No further
episodes of syncope occurred, nor were any pVTs detected
by the ICD. Several months after her appointment in our
hospital in May 2005, when her ECG showed a QTc duration
of 575 ms (Figure 1A), she got pregnant, and she gave birth
to a healthy girl at 29 weeks’ gestation (in March 2006).
At her follow-up appointment in November 2006, we
observed for the ﬁrst time a normalized QTc duration of 410
ms (Figure 1B). During several follow-up visits in 2007, her
QTc duration continued to be normalized (May 2007, QTc of
400 ms; December 2007, QTc of 410 ms). We wondered
about a possible explanation for this QTc normalization and
realized that our patient was breastfeeding until March 2007.
Additionally, she had a progesterone-releasing intraute-
rine device implanted in May 2006—and was hence underprogesterone treatment while visiting our hospital in May
2007. The progesterone-releasing intrauterine device was
removed in October 2007, and she subsequently became
pregnant; shortly afterwards, in December 2007, she still had
a normalized QTc duration (Figure 1C). From April until
August 2008, she received weekly intramuscular 17α-
hydroxyprogesterone caproate injections to prevent preterm
birth; in August 2008, she delivered her second child 1
month prematurely. ECG controls in February, June, and
August 2009, performed while the patient continued breast-
feeding, continued to show normalized QTc intervals of
around 400 ms. It was not until her follow-up visit in August
2011, when she was no longer breastfeeding or on hormone-
based contraceptive, that her ECG showed a prolonged QTc
duration of 497 ms (Figure 1D) for the ﬁrst time since 2005.Discussion
We here present the ﬁrst series of ECG recordings of an
individual LQTS patient with pronounced intra-individual
changes of QTc duration (ie, a normalization of QTc) during
pregnancy, while breastfeeding, and while using a
progesterone-releasing intrauterine device. The ECG alter-
ations strongly indicate a hormonal inﬂuence on QT interval
duration in inherited LQTS.QTc interval normalization during pregnancy
Although our patient had very long baseline heart rate–
corrected QT intervals ranging from 500 to 575 ms, her QTc
normalized during pregnancy (410 ms). This can likely be
attributed to the effects of increased progesterone levels
during pregnancy8 (Figure 2), as similarly observed in
patients with acquired, drug-induced LQTS variant, who
have a less pronounced drug-induced QTc prolongation and
hence shorter QTc during the luteal phase (with high
progesterone levels) than during menstruation and the
follicular phase (with high estradiol levels)4 (Figure 2).
Moreover, animal studies have demonstrated similar QT-
shortening progesterone effects and have provided insights
into underlying mechanisms9: In a transgenic LQT2 rabbit
model mimicking the human LQTS phenotype with QT
prolongation, spontaneous pVT, and sudden cardiac death,10
we have previously demonstrated that progesterone shortens
cardiac repolarization by decreasing the L-type Ca2þ current
ICa,L.
11 In addition, in guinea pigs, progesterone was shown
to shorten action potential duration by increasing the slow
delayed rectiﬁer Kþ current IKs.
12
While previous animal studies have reported that physio-
logical estradiol levels decrease IKr currents,
12 causing a
longer QT and a higher propensity for long QT–related
arrhythmia, a recent clinical study points to a shortening of
QTc during pregnancy in healthy subjects owing to very high
estradiol levels going along with an unexpected increased
HERG-channel trafﬁcking to the membrane and increased
IKr current densities
6
—indicating that very high estradiol
levels during pregnancy may have contributed similarly as
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Figure 1 A: Electrocardiogram (ECG) recording from our patient in May 2005 showing a very long heart rate–corrected QT interval (QTc) of 575 ms (QT 560
ms, RR 960 ms). B: ECG recording from the same patient in November 2006 during the postpartum period while under progesterone-releasing intrauterine
device treatment, showing for the ﬁrst time a normalized QTc interval of 410 ms (QT 360 ms, RR 750 ms).C: ECG recording from our patient during pregnancy
in December 2007, still showing a normalized QTc of 410 ms (QT 350 ms, RR 720 ms).D: ECG recording from the same patient after stopping breastfeeding in
August 2011 showing—for the ﬁrst time since 2005—again a QTc interval duration within her initial range of 497 ms (QT 500 ms, RR 990 ms). All traces were
acquired at a speed of 25 mm/s.
225Odening et al QT Duration in LQTS During Pregnancy and Postpartumprogesterone to the pregnancy-associated QT shortening/
normalization observed in our patient.
Moreover, in our patient, a polymorphism in KCNE1/
minK, the beta-subunit to KvLQT1 to form IKs, wasdetected. This polymorphism is known to modulate the
clinical phenotype in LQTS patients (QTc, arrhythmogenic
events)7 in a sex-speciﬁc manner, with additional QT
prolongation in male but not in female patients, suggesting
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Figure 2 Illustration of progesterone (Prog; blue, pg/mL) and estradiol (EST; red, ng/mL) levels and Prog/EST ratios in women during menstrual cycle,
pregnancy, and postpartum phase. Indicated are heart rate–corrected QT interval (QTc) durations in our patient at baseline, during pregnancy, and during
postpartum while breastfeeding. Hormone levels from references.8,13–15
Heart Rhythm Case Reports, Vol 2, No 3, May 2016226that this polymorphism might be susceptible to differential
sex hormonal inﬂuence and could thus contribute to proges-
terone’s particularly pronounced QT interval–shortening
effects observed in this patient.QTc interval normalization during the
postpartum phase
During the postpartum phase, our patient continued to
exhibit a normalized QTc duration. Two different hormonal
mechanisms likely accounted for this observation: ﬁrst, the
progesterone-releasing intrauterine device our patient used
for contraception during the postpartum phase after her ﬁrst
pregnancy; and second, the fact that she was breastfeeding
during both postpartum periods. Progesterone-releasing
intrauterine devices are known to increase local progesterone
levels in the uterus as well as systemic serum progesterone
levels (increase of serum progesterone concentration by 200
pg/mL, Mirena Data Sheet; Bayer). While using this intra-
uterine device, our patient hence continued to beneﬁt from
the QT-shortening effect of progesterone.11 During her
second postpartum phase, our patient had ceased to use a
progesterone-containing contraceptive, but she continued to
have a shortened QTc interval; this is likely due to the fact
that she was breastfeeding. In the early postpartum period,
serum progesterone and estradiol levels are known to quickly
decrease13 (Figure 2). Additionally, breastfeeding impedes
normal ovarian cycles by disrupting the pulsatile release of
gonadotropin-releasing hormone from the hypothalamus and
of luteinizing hormone from the pituitary, which results in a
reduced follicular estradiol production, thus maintaining the
reduced estradiol serum level13 (Figure 2). We have pre-
viously demonstrated that physiological estradiol prolongs
QT duration by increasing ICa,L, while the removal (ovar-
iectomy) shortens QT duration in transgenic LQT2 rabbitmodels.11 Consecutively, it is likely that the reduced
estradiol levels during breastfeeding similarly contributed
to the QTc normalization in our LQTS patient.
Hormone effects on the arrhythmogenic risk
It is known that the risk for arrhythmias in LQTS patients
decreases during pregnancy and increases during the post-
partum phase,3 although in these databases, breastfeeding
status was not recorded. In our patient, we observed
pronounced progesterone-related effects on QTc duration but
no changes in the arrhythmogenic risk. Since pVTs are
relatively rare events in LQTS patients, it is nearly impossible
to clearly and conclusively identify potential pro- or antiar-
rhythmic effects in one single individual. Moreover, our patient
did not have any pVTs since August 2000, when she got an
ICD implanted and her beta-blocker dosage was increased.
In transgenic LQT2 rabbits, however, we have previously
reported an antiarrhythmic, protective effect of progesterone
that may contribute to the overall reduced arrhythmogenic
risk in LQTS patients during pregnancy, and a proarrhythmic
effect of estradiol.11 To evaluate the antiarrhythmic effect of
progesterone in human LQTS patients in detail, prospective
case-control studies are thus warranted.
Conclusion
Here we report the case of an LQTS patient with pronounced
intra-individual differences in QTc duration during phases of
varying sex hormone levels—a shortening/normalization of
QTc duration owing to increased progesterone levels during
pregnancy and while using a progesterone-releasing intra-
uterine device, and owing to the pronounced reduction of the
QTc-prolonging effect of estradiol when breastfeeding—
indicating that it may be of clinical importance to consider
the hormonal status of an LQTS patient when assessing QTc
227Odening et al QT Duration in LQTS During Pregnancy and Postpartumduration. Consecutively, to adequately assess the risk of an
individual LQTS patient, it may be reasonable to analyze
QTc intervals during different phases of the menstrual cycle,
as well as during pregnancy and the postpartum phase.References
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